Multiplexed diagnostics market to witness substantial growth by 2025

The research report on ‘global multiplexed diagnostics market’ provides a deep dive analysis of this business vertical in terms of the growth opportunities, revenue estimations, final market valuation, and other factors which are anticipated to impact the sales garnered during 2020-2025


Selbyville, Delaware, June 01, 2020 (GLOBE NEWSWIRE) -- Worldwide multiplexed diagnostics market accrued revenues worth USD 9213.27 million in 2019 and is predicted to showcase significant growth between the years 2020 and 2025. Increasing focus on R&D activities towards developing next-generation sequencing solutions along with shifting preferences towards adopting advanced medical technologies and devices are major factors driving the growth of multiplexed diagnostics market.

According to the report, multiplexed diagnostics market has been fragmented into several segments including product, end user, and regions. The study emphasizes on the individual market share and overall segment valuation as well as prevailing and projected growth rates of every listed segment.  

There has been an upsurge in the demand for medical equipment that allow for simultaneous testing of various samples to save energy and time during operations. Additionally, growing population of baby boomers coupled with increased pervasiveness of various chronic and life threatening conditions are aiding the market expansion. Rising adoption of sedentary lifestyle and high occurrence of contagious diseases is also fostering the demand for multiplexed diagnostic devices.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2679117/

Multiplexed diagnostics are observing extensive adoption across clinical researchers, medical professionals, and diagnostic laboratories. In addition, increasing awareness pertaining to benefits of advanced and automated multiplexed diagnostic products is stimulating the industry outlook. 

Impact of COVID-19 pandemic

The emergence COVID-19 pandemic has resulted in high production and adoption of multiplexed diagnostic testing solutions across the healthcare sector, which in turn is favoring the market scenario.

Product insights

Global multiplexed diagnostics industry is fragmented into product types, end-user landscape, and regional contribution.

Speaking of the product spectrum, the market is further split into consumables, software & services, and instruments. The consumables segment is expected to grow significantly during the forecast period. Growing demand for advanced consumables among academic and medical researchers in consort with increasing spending towards reagents and assays for research applications are fueling the segmental share, cites the study.

Citing the end-use landscape, the multiplexed diagnostic market is bifurcated into clinical research, pharmaceuticals, diagnostic laboratories, and hospitals. The diagnostic laboratories segment is slated to record momentous growth in the ensuing years. Rising adoption of advanced instruments and consumables by clinicians for conducting studies and tests of genomes is complementing the industry dynamics. Moreover, the COVID-19 pandemic has compelled various healthcare professionals to use multiplexed diagnostic products in order to perform high volume tests.

Regional Analysis

The North America multiplexed diagnostic industry is anticipated to showcase substantial growth during the study period, followed by Europe and Asia-Pacific. Factors such as rising prevalence of Alzheimer’s among elderly population along with increasing consumption of medicinal services are promoting the business scenario in North America.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-multiplexed-diagnostics-market-analysis-by-product-type-consumables-instruments-software-services-end-user-by-region-by-country-2020-edition-market-insights-covid-19-impact-competition-and-forecast-2020-2025

Competitive Analysis

The major contenders in global multiplexed diagnostic industry are GenMark Diagnostics Inc., Thermo Fischer Scientific Inc., Hoffmann-La Roche AG, Abbott Laboratories, Luminex Corp., Illumina Inc., Bio-rad Laboratories Inc., Biomerieux, Agilent Technologies Inc. and Becton, Dickinson & Co. among others.

Global Multiplexed Diagnostics Market by Type Analysis (2020-2025)

Consumables

Instruments

Software & Services

Global Multiplexed Diagnostics Market by End-Use Analysis (2020-2025)

Hospitals

Diagnostics Laboratories

Pharmaceuticals

Clinical Research

Global Multiplexed Diagnostics Market by Regional Analysis (2020-2025)

North America

  • United States
  • Canada

Europe

  • U.K.
  • Germany
  • Grance
  • Spain

Asia-Pacific

  • China
  • India
  • South Korea
  • Japan

Global Multiplexed Diagnostics Market by Competitive Analysis (2020-2025)

  • Agilent Technologies Inc.
  • Becton, Dickinson & Co.
  • Biomerieux
  • Bio-rad Laboratories Inc.
  • Illumina Inc.
  • Luminex Corp.
  • Abbott Corp.
  • Hoffmann-La Roche AG
  • Thermo Fisher Scientific aG
  • GenMark Diagnostics Inc.

Table of Content:

1. Report Scope and Methodology

1.1 Research Methodology

1.2 Executive Summary

2. Strategic Recommendations

3. Global Multiplexed Diagnostics Market: Product Outlook

4. Global Multiplexed Diagnostics Market: Sizing and Forecast

4.1 Market Size, By Value, Year 2015-2025

5. Global Multiplexed Diagnostics Market Segmentation By Product

5.1 Competitive Scenario of Global Multiplexed Diagnostics Market a?? By Product

5.2 By Consumablesa?? Market Size and Forecast (2020-2025)

5.3 By Instruments- Market Size and Forecast (2020-2025)

5.4 By Software and services- Market Size and Forecast (2020-2025)

6. Global Multiplexed Diagnostics Market Segmentation By End User

6.1 Competitive Scenario of Global Multiplexed Diagnostics Market a?? By End User

6.2 By Hospitalsa?? Market Size and Forecast (2020-2025)

6.3 By Diagnostics Laboratories- Market Size and Forecast (2020-2025)

6.4 By Pharmaceuticals- Market Size and Forecast (2020-2025)

6.5 By Clinical Research - Market Size and Forecast (2020-2025)

7. Global Multiplexed Diagnostics Market: Regional Analysis

7.1 Competitive Scenario of Global Multiplexed Diagnostics: By Region

8. North America Multiplexed Diagnostics Market: Segmentation By Product and End User (2020-2025)

9. Europe Multiplexed Diagnostics Market: Segmentation By Product and End User (2020-2025)

10. APAC Multiplexed Diagnostics Market: Segmentation By Product and End User (2020-2025)

11. Global Multiplexed Diagnostics Market Dynamics

11.1 Global Multiplexed Diagnostics Market Drivers

11.2 Global Multiplexed Diagnostics Market Restraints

11.3 Global Multiplexed Diagnostics Market Trends

12. Market Attractiveness

12.1 Market Attractiveness Chart of Global Multiplexed Diagnostics Market - By Product (Year 2025)

12.2 Market Attractiveness Chart of Global Multiplexed Diagnostics Market - By End User (Year 2025)

12.3 Market Attractiveness Chart of Global Multiplexed Diagnostics Market - By Region, By Value, (Year-2025)

13. Competitive Landscape

13.1 Mergers and Acquisitions

13.2 Market Share Analysis

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)

Related Report:

Rapid Influenza Diagnostic Tests (RIDT) Market Size Share & Forecast, 2019 – 2025

Rapid Influenza Diagnostic Tests Market will exceed USD 689.0 million by 2025, as per a new research report. Growing number of infectious diseases and viral infections across the world will boost the global rapid influenza diagnostic test market growth over forecast period. Rapid influenza diagnostic test (RIDT) are used for diagnosis and treatment of highly contagious diseases caused due to airborne route and physical contact. RIDT provides several advantages such as accurate detection and diagnosis of flu and other viral infections. Thus, increasing rate of viral infections and flu will significantly escalate the rapid influenza diagnostic tests market growth over the forecast timeframe.


Rise in global awareness of flu among geriatric population will result into lucrative growth of rapid influenza diagnostic tests market. According to the Centre for Disease Control and Prevention (CDC), around 9.3 to 49 million people suffer from influenza in the U.S. each year.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

 

Kontaktdaten